A Pharmaceutical giant, Wellcome and the Bill & Melinda Gates Foundation have announced funding, to advance a tuberculosis (TB) vaccine candidate, M72/AS01E (M72), through a Phase III clinical trial.
Trending
- Lagos residents blame tree loss for rising heat
- NUJ Sokoto urges political actors to shun inflammatory campaigns ahead of 2027
- Group demands probe into deaths of 37 miners in NSCDC custody
- Cross River plans organised ranching to curb farmer-herder conflicts
- Trump bars CNN, MS NOW, Politico from White House
- FG trains 200 sheep, goat farmers in Kano
- NiHSA issues high flood risk alert for 15 states
- FABE Foundation pushes food waste sorting for cleaner communities
